{"title":"治疗妊娠期骨盆疼痛的最佳运动塑形天数。系统回顾和剂量反应荟萃分析","authors":"Joaquín Salazar-Méndez , Rodrigo Núñez-Cortés , Iván Cuyul-Vásquez , Sergio Sazo-Rodriguez , Joaquín Calatayud , Eduardo Guzmán-Muñoz , Anyela Aguayo , Benjamín Carrasco , Areli González , Luis Suso-Martí","doi":"10.1016/j.physio.2024.101418","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To determine the optimal dose and short-term effectiveness of kinesiotaping (KT) on pain intensity and disability in pregnant women with lumbo-pelvic pain.</div></div><div><h3>Data sources</h3><div>MEDLINE (via PubMed Central), CINAHL, Epistemonikos, Scopus, and Web of Science from inception to 21st March 2023.</div></div><div><h3>Study selection</h3><div>We included randomized controlled trials (RCT) conducted on pregnant women with lumbo-pelvic pain treated with KT.</div></div><div><h3>Data extraction</h3><div>The outcomes included pain intensity and disability. ROB-2 and GRADE were used to assess the risk of bias and the certainty of the evidence, respectively. A random effects meta-analysis was performed using the standardized mean difference (SMD) and the corresponding 95% confidence interval (CI). The dose-response association was evaluated using a restricted cubic spline model.</div></div><div><h3>Data synthesis</h3><div>Seven RCTs involving 527 patients were included. Meta-analysis revealed a statistically significant effect in favor of KT on pain intensity (SMD = −1.71; 95% CI = −2.51 to −0.90; <em>P</em> = <0.001) and on disability (SMD = −1.15; 95% CI = −2.29 to −0.02; <em>P</em> = <0.001). The total duration of KT use ranged from 5 to 35 days. It was estimated that a dose of 5–10 days exceeded the minimal clinically important difference (MCID) for pain intensity (mean difference at 10 days = −2.63; 95% CI = −3.05 to −2.22). Low certainty of evidence was identified for both outcomes.</div></div><div><h3>Conclusions</h3><div>In pregnant women with lumbo-pelvic pain, the use of KT for 5 to 10 days produces a short-term reduction in pain intensity that exceeds the MCID, with a low certainty of evidence.</div></div><div><h3>Systematic Review Registration Number</h3><div>Systematic Review Registration Number PROSPERO CRD42023388174.</div></div><div><h3>Contribution of Paper</h3><div><ul><li><span>•</span><span><div>The meta-analysis showed that KT reduces pain intensity and improves disability in women with lumbo-pelvic pain.</div></span></li><li><span>•</span><span><div>A duration of 5 to 10 days of KT is sufficient to exceed the minimal clinically important difference (MCID) for pain intensity.</div></span></li><li><span>•</span><span><div>Studies of high methodological quality with longer follow-up are needed.</div></span></li></ul></div></div>","PeriodicalId":54608,"journal":{"name":"Physiotherapy","volume":"125 ","pages":"Article 101418"},"PeriodicalIF":3.1000,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimal days of application of kinesiotaping for the treatment of lumbo-pelvic pain during pregnancy. A systematic review and dose-response meta-analysis\",\"authors\":\"Joaquín Salazar-Méndez , Rodrigo Núñez-Cortés , Iván Cuyul-Vásquez , Sergio Sazo-Rodriguez , Joaquín Calatayud , Eduardo Guzmán-Muñoz , Anyela Aguayo , Benjamín Carrasco , Areli González , Luis Suso-Martí\",\"doi\":\"10.1016/j.physio.2024.101418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To determine the optimal dose and short-term effectiveness of kinesiotaping (KT) on pain intensity and disability in pregnant women with lumbo-pelvic pain.</div></div><div><h3>Data sources</h3><div>MEDLINE (via PubMed Central), CINAHL, Epistemonikos, Scopus, and Web of Science from inception to 21st March 2023.</div></div><div><h3>Study selection</h3><div>We included randomized controlled trials (RCT) conducted on pregnant women with lumbo-pelvic pain treated with KT.</div></div><div><h3>Data extraction</h3><div>The outcomes included pain intensity and disability. ROB-2 and GRADE were used to assess the risk of bias and the certainty of the evidence, respectively. A random effects meta-analysis was performed using the standardized mean difference (SMD) and the corresponding 95% confidence interval (CI). The dose-response association was evaluated using a restricted cubic spline model.</div></div><div><h3>Data synthesis</h3><div>Seven RCTs involving 527 patients were included. Meta-analysis revealed a statistically significant effect in favor of KT on pain intensity (SMD = −1.71; 95% CI = −2.51 to −0.90; <em>P</em> = <0.001) and on disability (SMD = −1.15; 95% CI = −2.29 to −0.02; <em>P</em> = <0.001). The total duration of KT use ranged from 5 to 35 days. It was estimated that a dose of 5–10 days exceeded the minimal clinically important difference (MCID) for pain intensity (mean difference at 10 days = −2.63; 95% CI = −3.05 to −2.22). Low certainty of evidence was identified for both outcomes.</div></div><div><h3>Conclusions</h3><div>In pregnant women with lumbo-pelvic pain, the use of KT for 5 to 10 days produces a short-term reduction in pain intensity that exceeds the MCID, with a low certainty of evidence.</div></div><div><h3>Systematic Review Registration Number</h3><div>Systematic Review Registration Number PROSPERO CRD42023388174.</div></div><div><h3>Contribution of Paper</h3><div><ul><li><span>•</span><span><div>The meta-analysis showed that KT reduces pain intensity and improves disability in women with lumbo-pelvic pain.</div></span></li><li><span>•</span><span><div>A duration of 5 to 10 days of KT is sufficient to exceed the minimal clinically important difference (MCID) for pain intensity.</div></span></li><li><span>•</span><span><div>Studies of high methodological quality with longer follow-up are needed.</div></span></li></ul></div></div>\",\"PeriodicalId\":54608,\"journal\":{\"name\":\"Physiotherapy\",\"volume\":\"125 \",\"pages\":\"Article 101418\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physiotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0031940624004279\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"REHABILITATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physiotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0031940624004279","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"REHABILITATION","Score":null,"Total":0}
引用次数: 0
摘要
数据来源MEDLINE（通过PubMed Central）、CINAHL、Epistemonikos、Scopus和Web of Science（从开始到2023年3月21日）。研究选择我们纳入了对腹盆腔疼痛孕妇进行KT治疗的随机对照试验（RCT）。采用 ROB-2 和 GRADE 分别评估偏倚风险和证据的确定性。采用标准化平均差（SMD）和相应的95%置信区间（CI）进行随机效应荟萃分析。数据综合纳入了涉及 527 名患者的七项研究。Meta分析显示，KT对疼痛强度（SMD = -1.71; 95% CI = -2.51 to -0.90;P=<0.001）和残疾（SMD = -1.15; 95% CI = -2.29 to -0.02;P=<0.001）的影响具有统计学意义。使用 KT 的总时间从 5 天到 35 天不等。据估计，5-10 天的剂量超过了疼痛强度的最小临床重要差异 (MCID)（10 天的平均差异 = -2.63；95% CI = -3.05 至 -2.22）。结论在患有腹盆腔疼痛的孕妇中，使用 KT 5 至 10 天可在短期内减轻疼痛强度，其效果超过了最小临床意义差值（MCID），但证据的确定性较低。系统综述注册号系统综述注册号 PROSPERO CRD42023388174。论文贡献--荟萃分析表明，KT可减轻腹盆腔疼痛妇女的疼痛强度并改善残疾状况--持续5至10天的KT足以超过疼痛强度的最小临床意义差异（MCID）--需要方法学质量高且随访时间更长的研究。
Optimal days of application of kinesiotaping for the treatment of lumbo-pelvic pain during pregnancy. A systematic review and dose-response meta-analysis
Objective
To determine the optimal dose and short-term effectiveness of kinesiotaping (KT) on pain intensity and disability in pregnant women with lumbo-pelvic pain.
Data sources
MEDLINE (via PubMed Central), CINAHL, Epistemonikos, Scopus, and Web of Science from inception to 21st March 2023.
Study selection
We included randomized controlled trials (RCT) conducted on pregnant women with lumbo-pelvic pain treated with KT.
Data extraction
The outcomes included pain intensity and disability. ROB-2 and GRADE were used to assess the risk of bias and the certainty of the evidence, respectively. A random effects meta-analysis was performed using the standardized mean difference (SMD) and the corresponding 95% confidence interval (CI). The dose-response association was evaluated using a restricted cubic spline model.
Data synthesis
Seven RCTs involving 527 patients were included. Meta-analysis revealed a statistically significant effect in favor of KT on pain intensity (SMD = −1.71; 95% CI = −2.51 to −0.90; P = <0.001) and on disability (SMD = −1.15; 95% CI = −2.29 to −0.02; P = <0.001). The total duration of KT use ranged from 5 to 35 days. It was estimated that a dose of 5–10 days exceeded the minimal clinically important difference (MCID) for pain intensity (mean difference at 10 days = −2.63; 95% CI = −3.05 to −2.22). Low certainty of evidence was identified for both outcomes.
Conclusions
In pregnant women with lumbo-pelvic pain, the use of KT for 5 to 10 days produces a short-term reduction in pain intensity that exceeds the MCID, with a low certainty of evidence.
Systematic Review Registration Number
Systematic Review Registration Number PROSPERO CRD42023388174.
Contribution of Paper
•
The meta-analysis showed that KT reduces pain intensity and improves disability in women with lumbo-pelvic pain.
•
A duration of 5 to 10 days of KT is sufficient to exceed the minimal clinically important difference (MCID) for pain intensity.
•
Studies of high methodological quality with longer follow-up are needed.
期刊介绍：
Physiotherapy aims to publish original research and facilitate continuing professional development for physiotherapists and other health professions worldwide. Dedicated to the advancement of physiotherapy through publication of research and scholarly work concerned with, but not limited to, its scientific basis and clinical application, education of practitioners, management of services and policy.
We are pleased to receive articles reporting original scientific research, systematic reviews or meta-analyses, theoretical or debate articles, brief reports and technical reports. All papers should demonstrate methodological rigour.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
